Published on 4 May 2024 on Simply Wall St. via Yahoo Finance

Bristol-Myers Squibb (NYSE:BMY) shareholders have endured a 33% loss from investing in the stock a...

It's easy to match the overall market return by buying an index fund. When you buy individual stocks, you can make higher profits, but you also face the risk of under-performance. Investors in Bristol-Myers Squibb Company (NYSE:BMY) have tasted that bitter downside in the last year, as the share price dropped 35%. That's disappointing when you consider the market returned 26%. Even if you look out three years, the returns are still disappointing, with the share price down32% in that time. Unfortunately the share price momentum is still quite negative, with prices down 16% in thirty days. This could be related to the recent financial results - you can catch up on the most recent data by reading our company report.

So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress.